软组织肉瘤基线MRI的尺寸评估:最长径、直径之和、直径乘积与体积——哪种测量方法最能预测患者结局?
本研究回顾性纳入2000至2017年在本肉瘤参考中心以治愈为目的治疗的连续成人下肢新诊断软组织肉瘤患者,比较基线MRI上最长径、直径乘积、直径之和及3D-COG体积对无转移生存的预后价值。多变量Cox模型显示各尺寸指标均与无转移生存相关,直径乘积模型在训练集和验证集的c-index最高,但与最长径模型无显著差异;各指标均与局部无复发生存或总生存无关,重复性ICC均>0.95。作者认为最长径因简便且性能良好,是纳入预后模型和列线图的最佳指标。
要点
- 基线MRI上最长径、直径乘积、直径之和及3D-COG体积均与下肢软组织肉瘤的无转移生存相关。
- 直径乘积模型的c-index在训练集为0.772、验证集为0.688,但与最长径模型无显著差异。
- 各尺寸指标均与局部无复发生存或总生存无关,三种测量方法的重复性ICC均>0.95。
核心结论
- 最长径因简便且性能良好,是纳入无转移生存预后模型和列线图的最佳指标。
研究设计与样本
- 回顾性研究,纳入2000至2017年在本肉瘤参考中心以治愈为目的治疗的连续成人下肢新诊断软组织肉瘤患者382例(训练集253例,验证集129例),基于治疗前MRI测量最长径、直径乘积、直径之和及3D-COG体积,采用多变量Cox回归建模并以c-index比较模型。
诊断标准与关键数值
- 多变量Cox回归中,尺寸增大与无转移生存降低相关:最长径HR=2.44(P=0.0018)、直径乘积HR=1.88(P=0.0009)、直径之和HR=1.52(P=0.0041)、3D-COG HR=1.08(P=0.0195);直径乘积模型c-index训练集0.772、验证集0.688,与最长径模型无显著差异;各测量方法ICC均>0.95。
临床应用与阅片要点
- 作者认为最长径因简便且性能良好,是纳入无转移生存预后模型和列线图的最佳指标。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The longest diameter (LD) is a strong prognostic factor for patients with soft-tissue sarcoma (STS). Other dimensional assessments, such as the sum of diameters (SoD), product of diameters (PoD), and volume (3D-COG - proposed by the Children Oncology Group), can be rapidly performed; however, their prognostic values have never been compared to LD. Our goal was to investigate their performance in improving patients' prognostication for STS of the lower limbs.
METHODS: All consecutive adults managed with curative intent at our sarcoma reference center for a newly diagnosed STS of the lower limbs between 2000 and 2017, with pre-treatment MRI, were included in this retrospective study. Multivariable Cox regression models were trained to predict metastasis-free survival (MFS) in a Training cohort of 66.7% patients based on LD, PoD, SoD, or 3D-COG (and systematically including age, histologic grade, histotype, radiotherapy, chemotherapy, and surgical margins as covariables). The models were then compared on a validation cohort of 33.3% patients using concordance indices (c-index). The same approach was applied for overall survival (OS) and local relapse-free survival (LFS). Measurement reproducibility among three readers was evaluated with an intraclass correlation coefficient (ICC).
RESULTS: 382 patients were included in the survival modeling (72/253 [28.5%] metastatic relapses in Training and 36/129 [27.9%] metastatic relapses in Validation). Higher dimensions were associated with lower MFS (multivariable hazard ratio [HR] = 2.44 and P = 0.0018 for LD; HR = 1.88 and P = 0.0009 for PoD, HR = 1.52 and P = 0.0041 for SoD; and HR = 1.08 and P = 0.0195 for 3D-COG). Higher c-indices were obtained with PoD model in Training (c-index = 0.772) and Validation (c-index = 0.688), but they were not significantly higher than those obtained with LD model. None of the measurements was associated with LFS or OS. All measurements demonstrated excellent ICC (> 0.95).
CONCLUSION: Regarding its simplicity and good performance, LD appeared as the best metric to incorporate in prognostic models and nomograms for MFS.
引用
- D'Agostino V, Ponti F, Martella C, et al. Dimensional assessment on baseline MRI of soft-tissue sarcomas: longest diameter, sum and product of diameters, and volume-which is the best measurement method to predict patients' outcomes? Radiol Med. 2024. PMID: 39424744. doi:10.1007/s11547-024-01895-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。